Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Video – The importance of efficient ideas

With the right idea, video is a powerful tool within any industry, with the wrong idea it can become a time-consuming money sponge. An efficient idea is a must.

Page & Page Health

- PMLiVE

Regeneron’s early stage bispecific shows promise

Bispecifics and antibody drug conjugates will challenge CAR-Ts

Celgene building

ASH18: CAR-T and drugs give new options for multiple myeloma

San Diego congress showcasing data in important haematology markets

- PMLiVE

FDA fast tracks Novartis’ SMA gene therapy

Gene therapy could be approved in first half of 2019, will challenge Biogen's Spinraza

- PMLiVE

Porterhouse celebrates 12 months of smarter insight-driven medical communications

Strategic scientific and medical communications agency, Porterhouse Medical Group, is celebrating the first birthday of Porterhouse Insights, its global research, insight and evidence consultancy.

Porterhouse Medical Group

- PMLiVE

How industry platforms can help transform outcomes-based contracting in healthcare

Could platforms unlock outcomes-based contracting at scale?

VR/AR – Dr Tim Ringrose

Four Health - Emerging Technologies Immersive content prescribed by doctors/HCPs to enable patients to understand:heir condition the reason for their medication how they can manage their health most effectively.

Four Agency Worldwide

Life Sciences 4.0 – Antony Rawlins

Four Health - Emerging Technologies When the human body is the biggest data platform, who will capture value? Progressions 2018 Life Sciences 4.0 - Securing value through data-driven platforms.

Four Agency Worldwide

The AI revolution – Ben Greenberg

Four Health - Emerging Technologies Artificial intelligence - Programmes with the ability to learn and reason like humans. Machine Learning - Algorithms with the ability to learn without being explicitly...

Four Agency Worldwide

- PMLiVE

NICE U-turn sees Opdivo backed as adjuvant therapy for skin cancer

But it is only available via the CDF for now

- PMLiVE

UK pharma Brexit pessimism deepens, as govt admits sector could be among worst hit

Political gridlock fuels fears ahead of 11 Dec vote

- PMLiVE

Shire’s angioedema drug Takhzyro claims EU approval

Approval shortly follows a green light in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links